Iron is essential for bacteria due to its involvement in multiple metabolic processes including respiration (heme-containing proteins, \[Fe--S\]-containing ferredoxins) and key enzymatic reactions (\[Fe--S\]-containing proteins, such as fumarase and aconitase of the TCA cycle).^[@ref1]^ Pathogenic bacteria must obtain iron from the host to support growth, but humans maintain extremely low concentrations of free iron, which are further reduced during infections.^[@ref2],[@ref3]^ In bacterial cells, iron homeostasis plays a pivotal role in guarding against iron-induced toxicity caused by the propensity of free iron to stimulate the formation of reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and the highly destructive hydroxyl radical.^[@ref4]^ Consequently, free levels of iron in bacteria are tightly regulated to ensure sufficiency for metabolic needs while preventing iron-induced toxicity.^[@ref5]^ In humans, iron is stored in ferritin (Ftn),^[@ref6]^ whereas in bacteria, iron reserves are stored in a homologous bacterial Ftn and in bacterioferritin (Bfr), of which the latter is present only in bacteria.^[@ref7],[@ref8]^ Ftns, bacterial Ftns, and Bfrs assemble from 24 subunits into a hollow spherical structure with an outer diameter of 120 Å and an inner diameter of 80 Å, in which ≈3500 iron atoms can be stored in the form of an Fe^3+^ mineral. Despite their similar spherical architecture, eukaryotic and prokaryotic Ftns and Bfrs share \<18% amino acid sequence homology. The unique primary sequence of each type of ferritin-like molecule strongly influences the packing of the corresponding 24-mer protein shells as well as their function.^[@ref9],[@ref10]^

Bfrs are unique in possessing intrinsic heme groups, which are bound at 2-fold intersubunit sites by axial coordination of the heme-iron by methionine residues from adjacent subunits ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A). Hence, a 24-mer Bfr can be thought of as being assembled from 12 subunit dimers, each harboring a heme, which is buried deep below the protein surface, such that the heme propionates reach into the interior cavity ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B).^[@ref7]^ Bfrs function by (i) utilizing O~2~ or H~2~O~2~ to oxidize Fe^2+^ and store Fe^3+^ in their internal cavity (core) and (ii) accepting electrons to reduce Fe^3+^ in their core and mobilize Fe^2+^ to the cytosol.^[@ref11],[@ref12]^ In bacteria, the concentration of iron not incorporated in proteins (free iron), Fe^2+^, is maintained by a dynamic equilibrium between Fe^3+^ stored in ferritin-like molecules and Fe^2+^. Hence, one function of ferritin-like molecules is to maintain the cytosolic Fe^2+^ concentrations that enable Fur, the major iron-responsive regulator which is conserved in many bacteria,^[@ref13]^ to perform its broad range of regulatory functions that link iron homeostasis to broader bacterial metabolism.^[@ref14]−[@ref16]^ For example, Bfr mutants of *Mycobacterium tuberculosis* suffer from iron-mediated oxidative stress and are unable to persist in mice and guinea pig models of infection.^[@ref17],[@ref18]^ A Bfr-deficient mutant of *Nisseria gonorrheae* is growth-impaired in iron-limited medium and more sensitive to killing by hydrogen peroxide,^[@ref19]^ and in the plant pathogen *Erwinia chrysanthemi*, mutation of the *bfr* gene results in impaired iron utilization and growth defects.^[@ref20]^

![Structural organization of BfrB (PDB: 3IS8) and schematic representation of the process of iron mobilization from BfrB. (A) View of a subunit dimer harboring a heme molecule (red), which is coordinated by a conserved methionine from each of the subunits. (B) View of the BfrB interior cavity where iron mineral is stored; heme (red) is buried below the protein shell surface, with the heme propionates extending into the interior cavity. (C) Model of iron mobilization from the BfrB interior cavity, where electrons from NADPH are transferred via FPR and Bfd into the Fe^3+^ mineral stored in the core of BfrB.](bi-2015-00937b_0002){#fig1}

Early studies with *Escherichia coli* suggested that mobilization of iron from Bfr requires interactions with a ferredoxin, dubbed Bfd (bacterioferritin-associated ferredoxin) because the *bfd* gene is adjacent to the *bfr* gene.^[@ref21]−[@ref23]^ While mining the global genetic response of *Pseudomonas aeruginosa* to high and low iron conditions,^[@ref24]^ we noticed that of the ≈120 genes reported to be upregulated by low-iron conditions, the expression of *bfd* is upregulated 200-fold and that of a gene coding for a ferredoxin reductase (*fpr*) is increased 3-fold.^[@ref24]^ In contrast, the *bfrB* gene is downregulated under iron-limiting conditions.^[@ref25]^ The strong upregulation of the *bfd* gene in response to low iron led us to hypothesize that the Bfd protein functions in the mobilization of iron stored in BfrB by accepting electrons from the ferredoxin reductase (FPR) and transferring these to the ferric iron in BfrB for subsequent mobilization of Fe^2+^ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C).^[@ref26]^ We cloned the genes, characterized the *P. aeruginosa* BfrB, Bfd, and FPR proteins biochemically and structurally,^[@ref27],[@ref28]^ and showed that Bfd, FPR, and NADPH are sufficient to mobilize iron from BfrB *in vitro*.^[@ref26]^

More recently, we reported the X-ray crystal structure of the BfrB:Bfd complex.^[@ref12]^ The asymmetric unit contains three BfrB subunit dimers, each associated with a Bfd molecule, giving rise to a biological assembly consisting of a nearly spherical 24-mer BfrB with 12 Bfd molecules ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A). Each Bfd binds at an identical site on BfrB, at the interface of a subunit dimer, above each of the heme molecules, placing the \[2Fe--2S\] cluster of Bfd approximately 22 Å from the heme-iron in BfrB ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B). Studies in solution demonstrated that formation of the BfrB:Bfd complex enables the heme in BfrB to conduct electrons from the \[2Fe--2S\] cluster in Bfd to the mineral core, thus accelerating reduction of the Fe^3+^ mineral core and the mobilization of Fe^2+^.^[@ref12],[@ref26]^ A zoomed-in view of one of the 12 identical Bfd-binding sites on BfrB ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C) illustrates the proximity of the \[2Fe--2S\] cluster to the BfrB surface and shows the interactions that are likely important to stabilize the complex: (i) The side chain of Y^2^ in Bfd anchors in a cleft on the BfrB surface, which is formed by the side chains of E^81^ in subunit A (E~A~^81^) and L^68^ in subunit B (L~B~^68^), (ii) the side chain of L^5^ in Bfd fits in a pocket formed mostly by L~B~^68^, N~B~^70^, L~B~^71^, and L~A~^77^, (iii) the backbone NH group of M^1^ forms H-bonds with carboxyl side chains in E~A~^85^ and E~A~^81^ on BfrB and its side chain interacts hydrophobically with L~A~^77^, L~A~^78^, I~A~^79^, G~A~^80^, and C~A~^89^ on the BfrB surface, and (iv) the side chain of K^40^ in Bfd interacts hydrophobically with the side chain of K~A~^76^ in BfrB and forms hydrogen bonds with carbonyl oxygen of BfrB Q~B~^72^ and L~A~^74^.

![Structure of the BfrB:Bfd complex (PDB: 4E6K). (A) Twelve Bfd molecules bind a 24-mer BfrB at 12 identical binding sites. (B) Each Bfd molecule (cyan) binds at the interface of a BfrB subunit dimer, above a heme molecule. (C) Zoomed-in view of the BfrB:Bfd interface depicting residues in Bfd (cyan sticks) interacting with the BfrB surface; subunit A in BfrB is rendered green, and subunit B is gray. O, N, S, and Fe are shown in red, blue, yellow, and orange, respectively.](bi-2015-00937b_0003){#fig2}

In the present study, we examined the BfrB:Bfd interaction in solution with the aid of surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) and determined that the 12 Bfd-binding sites on BfrB, which are structurally identical, are also independent. Bfd binds at each of the sites on BfrB with a *K*~d~ of approximately 3 μM, and the interaction, although endothermic, is favored by a relatively large change in entropy. Having obtained a benchmark for the interaction between the two proteins, we mutated several residues that comprise the interface to alanine. These experiments revealed how particular side chains and the Bfd binding surface of BfrB contribute to the stability of the complex and to the Bfd-promoted mobilization of core iron from BfrB. While conducting this work, we noticed that recombinant BfrB used in our prior studies contained an extra methionine at position zero (M^0^), immediately upstream from the initiator methionine. We used site-directed mutagenesis to eliminate M^0^ and demonstrated that M^0^ BfrB is structurally identical to wt BfrB and that M^0^ BfrB binds Bfd with a *K*~d~ indistinguishable from the *K*~d~ obtained for the association between Bfd and wt BfrB.

Experimental Procedures {#sec2}
=======================

Site-Directed Mutagenesis {#sec2.1}
-------------------------

Mutations were introduced to the recombinant *bfd* and *bfrB* genes^[@ref26]^ with the aid of the Quik Change mutagenesis kit (Stratagene, La Jolla, CA) using the manufacturer's instructions. Primer pair sequences are provided in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf). Mutations were confirmed by sequencing (ACGT Inc., Wheeling, IL). The C^43^S mutant of Bfd is more stable to purification and manipulation but has the same functional and spectroscopic properties as those of wt Bfd; just as important, C43 is not a ligand to the \[2Fe--2S\] cluster, and it is far from the area used by Bfd to bind BfrB.^[@ref12],[@ref26]^ Consequently, the C^43^S mutant will be referred to as wt Bfd in this article. The following mutations were introduced to the wt *bfd* gene: Y^2^A, Y^2^F, L^5^A, and K^40^A. The extra methionine (M^0^) in recombinant BfrB was removed by eliminating the corresponding codon in the *bfrB* gene. BfrB with the correct sequence is termed wt BfrB, and BfrB harboring the extra methionine will be referred to as M^0^ BfrB.

Protein Expression and Purification {#sec2.2}
-----------------------------------

Recombinant FPR and Bfd (wt and mutants) were expressed and purified as described previously.^[@ref28]^ Recombinant BfrB (wt and all mutants) were expressed and purified using previously reported protocols^[@ref12],[@ref26]^ with some modifications: *E. coli* Arctic express RIL cells harboring the recombinant pET11a/*bfrB* construct were cultured overnight at 37 °C in 50 mL of LB medium containing 100 μg/mL ampicillin and 20 μg/mL gentamicin. The cells were then cultured in 1 L of fresh LB containing no antibiotics for 3 h at 30 °C, transferred to a shaker incubator pre-equilibrated at 10 °C, and incubated for 45 min before protein expression was induced by addition of 1 mM 1-thio-[d]{.smallcaps}-galactopyranoside (IPTG). Cells were cultured for an additional 48 h at 10 °C before they were harvested by centrifugation and stored at −20 °C. Cell paste was suspended in a solution containing 50 mM Tris-Base (pH 7.6), 5 mM dithiothreitol (DTT), 0.5 mM phenylmethanesulfonylfluoride (PMSF), and 0.5% Triton X-100 (Sigma) and sonicated on ice. Cell debris were pelleted by centrifugation at 4 °C and 19 500 rpm, and the supernatant was dialyzed against 50 mM Tris-Base (pH 7.6), loaded onto a Q-Sepharose Fast Flow column (12 cm × 2.5 cm i.d.) equilibrated with the same buffer, and eluted with a gradient of 0 to 600 mM NaCl. Fractions containing BfrB were dialyzed against 50 mM potassium phosphate buffer (pH 7.6) containing 1 mM tris(2-carboxyethyl)phosphine (TCEP), loaded onto a hydroxyapatite Bio-Gel column (10 cm × 2.5 cm i.d.) equilibrated with the same buffer, and eluted with a 50 to 800 mM potassium phosphate gradient (pH 7.6), 1 mM TCEP. Isolating fractions containing BfrB and repeating this chromatographic step yield pure BfrB. The separation of 24-mers from incompletely assembled protein was carried out by FPLC (AKTA GE Healthcare) in a Hiload 16/600 superdex 200 pg column equilibrated and eluted with 100 mM potassium phosphate (pH 7.0). BfrB purified in this manner is nearly devoid of heme. To reconstitute with heme, a previously described method^[@ref29]^ was used with some modifications: Hemin chloride was dissolved in 0.1 M sodium hydroxide solution and diluted with potassium phosphate buffer (100 mM, pH 7.0) to a final concentration of 1.5 mM. Insoluble material was removed by centrifugation. BfrB (3 μM) in 100 mM potassium phosphate (pH 7.0) and 1 M NaCl was equilibrated at 80 °C for 1 min in a dry bath (LabDoctor Dry Bath Plus), followed by the addition of a first aliquot of heme, which delivered 6 heme molecules per 24-mer BfrB, and the mixture was incubated for 10 min at 80 °C. The temperature was then increased to 90 °C prior to addition of a second aliquot of heme delivering 6 heme molecules per 24-mer BfrB, followed by incubation at 90 °C for 10 min. The temperature was then increased to 95 °C prior to addition of a third aliquot of heme delivering 6 heme molecules per 24-mer, followed by incubation of the mixture at 95 °C for 10 min. The resultant mixture was cooled on ice and loaded onto a Hiload 16/600 Superdex 200 pg column equilibrated and eluted with 100 mM potassium phosphate (pH 7.6) at 4 °C. The desired fractions were collected and supplemented with 1 mM TCEP. The heme content of BfrB was analyzed according to a previously described method.^[@ref26],[@ref30]^ Reconstitution of BfrB with an iron core was carried out as reported previously.^[@ref26]^ Upon addition of 500 Fe ions/BfrB, the protein solutions were incubated overnight at 4 °C and then passed through a Superdex 200 10/300 GL column. The content of iron in bacterioferritin, before and after reconstitution with an iron core, was measured using a previously reported protocol.^[@ref26],[@ref31]^

Crystallization and X-ray Diffraction Data Collection {#sec2.3}
-----------------------------------------------------

Crystallization experiments were conducted in Compact 300 sitting drop vapor diffusion plates (Rigaku Reagents) at 20 °C. Equal volumes of BfrB (10 mg/mL in 100 mM potassium phosphate, pH 7.6 and 1 mM TCEP) and crystallization solution were mixed and equilibrated against 75 μL of crystallization solution. All crystals were obtained from the Wizard 3-4 screen (Rigaku Reagents) except for the wt BfrB crystals, which employed the Cryo HT screen (Rigaku Reagents). All crystals were observed within 1 to 2 days. The observed morphology, crystallization conditions, and cryoprotectants are as follows. wt BfrB: Crystals displaying plate morphology were obtained in 1 to 2 days from condition H6 (30% (v/v) PEG 200, 100 mM Na acetate, pH 4.5, 200 mM sodium chloride). Crystals were transferred to a fresh drop of crystallant, which served as the cryoprotectant. L^68^A BfrB: Prismatic crystals from well E10 (50% (v/v) PEG 200, 100 mM Na cacodylate, pH 6.5, 200 mM magnesium chloride) were transferred to a drop of crystallant, which served as the cryoprotectant. L^68^A/E^81^A BfrB: Prismatic crystals from well A2 (30% (v/v) 2-methyl-2,4-pentanediol, 100 mM Na acetate, pH 4.6, 20 mM calcium chloride) were transferred to a fresh drop of crystallant, which served as the cryoprotectant. E^81^A BfrB: Plate shaped crystals from well F12 (2.4 M sodium malonate) were transferred to a drop of 3.4 M sodium malonate, which served as the cryoprotectant. E^85^A BfrB: Plate shaped crystals from well F4 (15% (v/v) PEG 550MME, 100 mM MES, pH 6.5) were transferred to a drop containing 25% PEG 550MME and 75% crystallant. Fe-soaked crystals of wt and L^68^A/E^81^A BfrB were prepared by soaking native crystals for 10 min in 50 mM FeCl~2~ freshly dissolved in crystallization solution and frozen in liquid nitrogen. X-ray diffraction data were collected at the Advanced Photon Source Beamline 17-ID (Argonne National Laboratory) using a Dectris Pilatus 6 M pixel array detector. All diffraction data sets were collected at λ = 1.0000 Å except for the iron-bound crystals, which were collected at λ = 1.720 Å in order to obtain the maximum iron anomalous signal. The anomalous difference maps were used to assign iron atoms to specific sites, and peak heights and *B-*factors of the iron atoms were compared for each particular structure.

Structure Solution and Refinement {#sec2.4}
---------------------------------

Intensities were integrated using XDS,^[@ref32]^ and the Laue class analysis and data scaling were performed with Aimless.^[@ref33]^ Structure solution was conducted by molecular replacement with Phaser^[@ref34]^ using a single subunit of a previously determined BfrB structure (PDB: 3IS7) as the search model. Refinement and manual model building were conducted with Phenix^[@ref35]^ and Coot,^[@ref36]^ respectively. Structure validation was conducted with Molprobity.^[@ref37]^ Disordered side chain atoms were truncated to the point where electron density could be observed. Further details are provided below, and relevant crystallographic data are provided in Table S1 of the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf).

### L^68^A BfrB {#sec2.4.1}

The highest probability Laue class was *mmm*, and the suggested space group was *P*2~1~2~1~2~1~, with *a* = 117.86 Å, *b* = 125.66 Å, and *c* = 169.99 Å. On the basis of the Matthew's coefficient^[@ref38]^ (*V*~m~ = 2.9 Å^3^/Da, 58% solvent), the asymmetric unit likely contained 12 molecules of BfrB. The top solution was obtained in the space group *P*2~1~22~1~, with 12 molecules in the asymmetric unit. Since *P*2~1~22~1~ is a nonstandard setting of *P*2~1~2~1~2, the data were reindexed using the operator (*h*,--*l*,*k*) to transform the reflections into the standard space group setting *P*2~1~2~1~2 with *a* = 117.86 Å, *b* = 169.99 Å, and *c* = 125.66 Å

Following initial refinement, large peaks of electron density were observed in the 4-fold pores and B-pores. The 4-fold pores of BfrB are typically occupied by K^+^ ions.^[@ref27]^ However, large peaks of positive electron density (*F*~o~ -- *F*~c~) greater than 3σ were observed at these sites when modeled as K^+^ ions. A phased anomalous difference map revealed peaks at the K^+^ binding sites of the 4-fold pore that were between 10σ and 11σ. Given that the crystals were obtained from cacodylate buffer and the maximum anomalous signal for arsenic is at approximately λ = 1.047 Å (f″ ∼ 3.9*e*^--^), it appeared that arsenic ions of some form occupied the 4-fold pore sites. The data for this structure were collected at λ = 1.0000 Å, which would still yield an appreciable anomalous signal (f″∼ 3.6*e*^--^). It was clear from the electron density, however, that a cacodylate ion was not bound to this region and thus the electron density was ultimately modeled as AsH~3~ ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)). It is unclear how this form of arsenic would be bound at this site, but perhaps it is due to impurities in the cacodylate buffer or due to reactivity with the TCEP that is present in the protein storage buffer. The B-pores also displayed large peaks of electron density, which were modeled as Mg^2+^ ions obtained from the crystallant. Most of the Mg^2+^ are hexacoordinated by water molecules, which also form contacts with residues in the B-pores ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)).

### L^68^A/E^81^A BfrB {#sec2.4.2}

The highest probability Laue class was −3, and the suggested space groups were *P*3, *P*3~1~, or *P*3~2~. On the basis of the Matthew's coefficient^[@ref38]^ (*V*~m~ = 2.9 Å^3^/Da, 57% solvent), the asymmetric unit likely contained 24 molecules of BfrB. All space groups with 3 point symmetry were tested, and the top solution was obtained in space group *P*3~2~ with 24 molecules in the asymmetric unit.

### E^81^A BfrB {#sec2.4.3}

The highest probability Laue class was *mmm*, with possible space groups *C*222 or *C*222~1~. On the basis of the Matthew's coefficient^[@ref38]^ (*V*~m~ = 2.9 Å^3^/Da, 55% solvent), the asymmetric unit likely contained 12 molecules of BfrB. The top solution was obtained in space group *C*222~1~.

### E^85^A BfrB {#sec2.4.4}

The highest probability Laue class was 4/*mmm*, with the highest probability space group being *P*4~2~2~1~2. On the basis of the Matthew's coefficient^[@ref38]^ (*V*~m~ = 2.8 Å^3^/Da, 56% solvent), the asymmetric unit likely contained 12 molecules of BfrB. All space groups with 422 point symmetry were tested, and the top solution (12 molecules/ASU) was obtained in space group *P*4~2~2~1~2.

Measurement of the BfrB:Bfd Binding Affinity by Surface Plasmon Resonance (SPR) {#sec2.5}
-------------------------------------------------------------------------------

SPR experiments were performed at 22 °C using a Biacore 3000 instrument (GE Healthcare). BfrB was immobilized on a CM5 sensor chip using amine coupling chemistry.^[@ref39]^ The sensor chip surface was preconditioned with 50 mM NaOH, 10 mM HCl, 0.1% SDS, and 0.085% H~3~PO~4~ and activated by injecting 0.1 M *N*-hydroxysuccinimide (NHS) and 0.4 M 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC) in water. The running buffer was PBS with 1.5 mM TCEP, pH 7.4. Immobilization of BfrB was carried out by flowing (10 μL/min) a 100 nM solution of BfrB in 10 mM sodium acetate buffer (pH 5.0) for 32.5 min, followed by quenching surface-activated sites not coupled to BfrB by flowing (10 μL/min) 1.0 M aqueous ethanolamine-HCl (pH 8.5) for 7 min. A cell activated by NHS/EDC and quenched by ethanolamine but not containing BfrB was used as the reference surface, and a cell immobilized with bovine serum albumin (BSA) was used as control. To determine the BfrB:Bfd binding affinity, a solution of Bfd in 50 mM potassium phosphate (pH 7.0), 150 mM NaCl, 5 mM DTT was simultaneously flowed (25 μL/min) over the cell containing immobilized BfrB, the reference cell, and the cell containing immobilized BSA at 25 μL/min. Bfd solutions with the following concentrations were used to construct a binding curve: 0.5, 1.0, 2.0, 5.0, 10.0, 20.0, and 40.0 μM. The corresponding responses were double-referenced by subtracting the bulk refractive index change caused by difference in buffer compositions as well as by subtracting the response from the reference cell. Experiments were conducted in triplicate.

Measurement of the BfrB:Bfd Binding Affinity by Isothermal Titration Calorimetry (ITC) {#sec2.6}
--------------------------------------------------------------------------------------

Prior to each experiment, BfrB and Bfd were exchanged into 100 mM potassium phosphate buffer (pH 7.0), 150 mM NaCl, and 1 mM TCEP by passage through a Superdex 200 10/300 GL or superdex 75 10/300 GL column, respectively. ITC was performed at 22 °C using a MicroCal auto ITC instrument (GE Healthcare). The cell was loaded with 1.45 mL of 18 μM Bfd and titrated with a total volume of 0.25 mL of 20 μM BfrB in 25 injections, each lasting 20 s and delivering 10.02 μL, with 300 s between injections. A similar titration of BfrB into buffer served as a control to measure the heat of dilution. The experiment was repeated three times.

Mobilization of Iron from BfrB {#sec2.7}
------------------------------

These experiments were carried out in an anaerobic chamber according to a previously described method^[@ref26]^ with small modifications: A 1 cm path-length cuvette was filled with a solution consisting of BfrB (0.18 μM) reconstituted with 500 ± 20 Fe^3+^ ions/BfrB, Bfd (0.9 μM), FPR (7.2 μM), and α,α′-bipyridine (bipy), 3 mM. The reactions leading to mobilization of Fe^2+^ from BfrB ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C) were initiated by addition of 1 mM NADPH, and the process was monitored by tracking the time-dependent formation of the \[Fe(bipy)~3~\]^2+^ complex, which absorbs at 523 nm. The percentage of iron released was calculated by normalizing the intensity of the 523 nm band to the intensity expected upon mobilization of the 500 iron ions stored in BfrB.

Results and Discussion {#sec3}
======================

Characterization of the BfrB:Bfd Interaction by SPR Shows That the 12 Bfd-Binding Sites on BfrB Are Identical and Independent {#sec3.1}
-----------------------------------------------------------------------------------------------------------------------------

The X-ray crystal structure of the BfrB:Bfd complex showed that each Bfd binds at the interface of a BfrB subunit, near the 2-fold axis of symmetry, placing the \[2Fe--2S\] cluster of Bfd approximately 22 Å from the heme-iron in BfrB.^[@ref12]^ Studies in solution showed that Bfd binding to BfrB makes the BfrB-heme conductive, accelerates reduction of the Fe^3+^ mineral core, and facilitates mobilization of Fe^2+^.^[@ref7],[@ref26]^ As part of this study, we investigated the binding affinity of the BfrB:Bfd complex using SPR. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A shows the reference- and baseline-subtracted responses obtained from flowing wt Bfd over wt BfrB immobilized on a sensor chip. At each Bfd concentration, the corresponding response reaches a plateau, indicating steady-state equilibrium. Plotting each response at steady state as a function of Bfd concentration results in the hyperbolic binding curve defined by the black circles in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B. The interpretive model used to fit these data is described below.

![Measuring the affinity of the BfrB:Bfd interaction using SPR. (A) Overlay of reference- and baseline-subtracted sensograms resulting from flowing wt Bfd solution of the indicated concentration over immobilized wt BfrB. (B) BfrB:Bfd binding affinity determined by steady-state affinity analysis. Responses at steady state are plotted as a function of Bfd concentration (black circles in top panel) and fitted to the model described by [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"} (solid line). The bottom panel shows the relative differences between the fitted and experimental data. A Scatchard plot is shown in the inset of the top panel.](bi-2015-00937b_0004){#fig3}

In the SPR experiments, BfrB was immobilized on the surface and free Bfd was in the flow. Hence, \[BfrB~f~\] is the concentration of immobilized BfrB not bound to Bfd, \[Bfd~f~\] is the concentration of Bfd in the flowing solution, which is maintained constant by the flow system, and \[BfrB:Bfd\] is the concentration of the protein complex at the surface. For a case where Bfd binding is homogeneous and the stoichiometry is 1:1, the expression for the dissociation constant (*K*~d~) can be written as in [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"},^[@ref40]^ where the total concentration of immobiled BfrB is given by \[BfrB~t~\] = \[BfrB~f~\] + \[BfrB:Bfd\].

Since the X-ray crystal structure showed that Bfd binds to multiple sites on BfrB, [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} was modified to [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, which indicates that *n* sites in BfrB can be occupied by Bfd, with corresponding dissociation constants.

The X-ray crystal structure of the BfrB:Bfd complex also showed that the Bfd molecules bind at 12 structurally identical binding sites on BfrB. Thus, assuming that the 12 Bfd binding sites on BfrB are identical and noninteracting, [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"} can be reduced to [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"},^[@ref40]^ which is similar to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}, except for the inclusion of the complex stoichiometry, *n*.

At each of the Bfd concentrations (\[Bfd~f~\]) used in the SPR experiments shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A, when the system reaches steady-state equilibrium (at the plateau), the concentration of the BfrB:Bfd complex at the surface is proportional to the magnitude of the SPR response at the pleateau, which is termed *R*~eq.~ Hence, [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"} can be rewritten as [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"}, where *R*~0~, corresponds to the response when every immobilized 24-mer BfrB molecule is bound by one Bfd molecule, and the remainder terms are defined as above. The value of *R*~0~ can be estimated from [eq [5](#eq5){ref-type="disp-formula"}](#eq5){ref-type="disp-formula"},^[@ref41]^ where *R*~immo~ is the SPR response obtained upon immobilizing BfrB, MW~BfrB~ is the molecular mass of BfrB (452 672 Da), and MW~Bfd~ is the molecular mass of Bfd (7984 Da).

Setting initial values of *n* = 12 and *R*~0~ = 520, respectively, and fitting the values of *R*~eq~ obtained from each \[Bfd~f~\] (circles in the plot of [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B) to [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"}, values for *K*~d~ = 3.3 ± 0.5 μM ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), *n* = 12.7, and *R*~0~ = 624 ± 18 were obtained. As can be seen from the fitted line in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B and from the small relative residuals, the binding curve is well-fitted by [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"}. In addition, the linear behavior observed from analysis of the binding curve by the Scatchard plot, which is a powerful tool for identifying deviations from simple binding models,^[@ref40]^ supports the idea implicit in [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"}, namely, that the 12 binding sites in BfrB are equivalent and independent.

###### Thermodynamic and Kinetic Parameters for the BfrB:Bfd Interaction[a](#t1fn1){ref-type="table-fn"}

                             *K*~d~ (μM)                                  *k*~a~ (μM^--1^ s^--1^)   *k*~d~ (s^--1^)   *Δ*H** (kcal/mol)   *Δ*S** (cal/(mol K))[b](#t1fn2){ref-type="table-fn"}   *Δ*G** (kcal/mol)[c](#t1fn3){ref-type="table-fn"}
  -------------------------- ------------------------------------------- ------------------------- ----------------- ------------------- ------------------------------------------------------ ---------------------------------------------------
  SPR equilibrium analysis   3.3 ± 0.5[d](#t1fn4){ref-type="table-fn"}                                                                                                                                                    
  SPR kinetic analysis       2.6 ± 0.4[d](#t1fn4){ref-type="table-fn"}         0.026 ± 0.002         0.069 ± 0.01                                                                                                         
  ITC analysis               4.2 ± 0.4[e](#t1fn5){ref-type="table-fn"}                                                    1.6 ± 0.3                            30.1 ± 0.7                                           --7.3 ± 0.1

The reported thermodynamic and kinetic parameters obtained from triplicate experiments at 22 °C.

Calculated from Δ*G* = *Δ*H* -- TΔ*S**

Calculated from Δ*G* = −*RT* ln(1/*K*~d~)

*K*~d~ obtained at pH 7.4

*K*~d~ obtained at pH 7.0

Having shown that the 12 binding sites on a BfrB molecule are identical and independent, kinetic analysis of the BfrB:Bfd interaction was carried out assuming the 1:1 binding model described by [eqs [6](#eq6){ref-type="disp-formula"}](#eq6){ref-type="disp-formula"} and [7](#eq7){ref-type="disp-formula"}, where BfrB~s~ indicates one of the 12 binding sites in each immobilized BfrB molecule, \[BfrB~ts~\] is the total concentration of binding sites (12/BfrB molecule) on the surface, \[BfrB~bs~\] is the concenration of BfrB sites bound to Bfd, *k*~a~ is the association rate constant, and *k*~d~ is the dissociation rate constant. [Equation [7](#eq7){ref-type="disp-formula"}](#eq7){ref-type="disp-formula"} can be rewritten in terms of the SPR response as [eq [8](#eq8){ref-type="disp-formula"}](#eq8){ref-type="disp-formula"}, where *R* is the response caused by Bfd binding and *R*~max~ is the response when all the binding sites are occupied by Bfd.^[@ref42]^ Hence, values of *k*~a~ and *k*~d~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) were obtained from global fitting of the SPR data to [eq [8](#eq8){ref-type="disp-formula"}](#eq8){ref-type="disp-formula"} ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}) with the aid of BIAevaluation software. Note that the ratio of the constants (*k*~a~/*k*~d~ = 2.6 μM) is very similar to the value of *K*~d~ obtained from steady-state analysis described above, an observation that strengthens the conclusion that the Bfd binding sites on BfrB are independent and equivalent.

![Kinetic analysis of the BfrB:Bfd interaction. Top: Reference- and baseline-subtracted sensograms obtained from flowing wt Bfd solution of the indicated concentration over immobilized wt BfrB shown in different colors. Corresponding fitted traces are shown in black. Relative residuals are shown in the bottom panel.](bi-2015-00937b_0005){#fig4}

Characterization of the BfrB:Bfd Interaction by ITC {#sec3.2}
---------------------------------------------------

The interaction between wt BfrB and wt Bfd was also studied by ITC at 22 °C. The top panel in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}, which shows the binding isotherms obtained from titrating Bfd with BfrB, indicates that formation of the BfrB:Bfd complex is an endothermic process. The ITC data were integrated, normalized for nonspecific heat effects, and fitted using a nonlinear least-squares algorithm (minimization of χ^2^) with the aid of the Origin software package provided by MicroCal. Since the 12 binding sites on BfrB are equivalent and independent, the data were fitted to the 1:1 binding model described by [eq [6](#eq6){ref-type="disp-formula"}](#eq6){ref-type="disp-formula"}, where the concentration of titrant (BfrB) is the concentration of Bfd-binding sites (subunit dimers). Fitting the integrated heats (bottom panel in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) allowed us to obtain the *Δ*H**, *Δ*S**, and **K**~d~ values listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, which indicate that the BfrB:Bfd association is entropically driven. Note that the value of *K*~d~ obtained from these measurements is in good agreement with the *K*~d~ value obtained from the SPR experiments, thus providing additional support for the idea that the 12 Bfd-binding sites in BfrB are identical and independent. Identical experiments (SPR and ITC) were carried out with M^0^ BfrB ([Figures S3 and S4](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)). The results show that the *K*~d~ values obtained by SPR (*K*~d~ = 3.8 ± 0.2 μM) and ITC (*K*~d~ = 2.6 ± 1.0 μM) are within error, indistinguishable from those obtained with wt BfrB. Hence, the M^0^ residue has no influence on the BfrB:Bfd association. Moreover, as will be shown below, M^0^ has no influence on the BfrB structure.

![Analysis of the BfrB:Bfd interaction using ITC. Top: Heat absorbed upon titrating BfrB into Bfd. Bottom: Integrated heats plotted against the BfrB~s~/Bfd mole ratio and fitted to the 1:1 binding model described by [eq [6](#eq6){ref-type="disp-formula"}](#eq6){ref-type="disp-formula"}.](bi-2015-00937b_0006){#fig5}

Dissecting the Interaction Surface in the BfrB:Bfd Complex {#sec3.3}
----------------------------------------------------------

The structure of the BfrB:Bfd complex shows that L^68^, E^81^, and E^85^ in BfrB interact with M^1^, Y^2^, and L^5^ in Bfd (see [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C), forming a contiguous set of interactions that is likely to contribute significantly to the stability of the complex. To study the relative contribution of these interactions to the formation of the complex, we prepared the L^68^A, E^81^A, E^85^A, L^68^A/E^81^A mutants of BfrB and the Y^2^A, Y^2^F, L^5^A, and K^40^A mutants of Bfd. It has been shown that in BfrB breathing motions of the protein shell link relatively remote sections in the structure and that, for example, mutations in some of the pores can affect the reactivity of relatively distant ferroxidase centers.^[@ref9]^ The main objective of the mutations introduced in wt BfrB for this study is to determine their effect on the stability of the BfrB:Bfd interaction and concomitant inhibition of mobilization of iron stored in the BfrB core. Consequently, we characterized the BfrB mutants to determine that the site-directed mutations, which were designed to affect only the BfrB:Bfd interaction, did not cause significant changes in the structure of the protein or its ability to oxidize Fe^2+^ and store Fe^3+^. The biochemical characterization is described immediately below, and the structural analysis is presented later, after we have discussed the functional implications.

Biochemical and Functional Characterization of BfrB Mutants {#sec3.4}
-----------------------------------------------------------

The ability of the mutant proteins to assemble into 24-mers was analyzed with the aid of a calibrated size exclusion column. The results show that retention volumes exhibited by all of the mutants are nearly identical to the retention volume displayed by wt BfrB ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)), indicating that all mutants assemble into 24-mers. Additionally, the UV--vis absorption spectrum displayed by each of the BfrB mutants is identical to that of wt BfrB and M^0^ BfrB ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)): The heme in the oxidized form gives rise to a Soret band at 418 nm, whereas in its reduced form, the Soret band is at 425 nm with peaks in the visible at 527 and 567 nm. In wt BfrB, the ratio *A*~280~/*A*~418~ = 0.67 is indicative of a 24-mer protein harboring 12 heme molecules.^[@ref26]^ In the UV--vis spectra obtained from each of the BfrB mutants, the *A*~280~/*A*~418~ ratio is also ≈0.67, indicating that the mutants also harbor 12 hemes in a 24-mer assembly. This conclusion is also supported by analysis of heme content.

The Fe^2+^ oxidation and Fe^3+^ uptake function of each mutant were evaluated by reconstituting each of the proteins with 500 iron ions and monitoring the process by UV--vis spectrophotometry, as described previously.^[@ref26],[@ref27]^ The spectral data ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)) obtained from titrating a solution of BfrB with aliquots delivering 50 Fe^2+^ ions/BfrB show a gradual increase in the absorption at 300 nm, which is associated with the growth of a Fe^3+^ mineral in the core of ferritin-like molecules.^[@ref26]^ After addition of 500 Fe ions/BfrB, the solution was incubated overnight at 4 °C and then passed through a Sephadex G-25 column. Subsequent determination of iron content in BfrB showed that each of the proteins captured \>450 Fe^3+^ ions/BfrB. Having determined that the BfrB mutants assemble into fully functional 24-mers capable of oxidizing Fe^2+^ and storing Fe^3+^ in their core, the effect of the mutations on the ability of Bfd to bind BfrB mutants and promote the mobilization of core iron was examined.

Mobilization of Core Iron from the BfrB Mutants Is Compromised {#sec3.5}
--------------------------------------------------------------

We have previously demonstrated that mobilization of Fe^3+^ stored in BfrB requires Bfd^[@ref12],[@ref26]^ and that the process of iron mobilization (shown schematically in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C) involves Bfd binding to BfrB, which permits electron transfer from the \[2Fe--2S\] cluster in Bfd to the core Fe^3+^ mineral in BfrB via its heme. Consequently, to determine the effect of the BfrB mutations on the ability of Bfd to bind and promote the mobilization of core Fe^3+^, we reconstituted wt and each of the BfrB mutants with 500 ± 20 Fe^3+^ ions in their core ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)). Mobilization of the iron core was monitored by UV--vis spectrophotometry, where the reaction mixture contained wt, BfrB, FPR, Bfd, and an excess of bipyridine (bipy), a Fe^2+^ chelator. Addition of excess NADPH initiates the reactions shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C, and the release of Fe^2+^ from BfrB is monitored by Δ*A*~523~, which tracks the time-dependent formation of the \[Fe(bipy)~3~\]^2+^ complex. The black circles in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A track Δ*A*~523~ normalized to the total absorbance change expected upon removal of the 500 iron ions from wt BfrB core. In comparison, the reaction carried out in the absence of Bfd (red circles, [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A) clearly demonstrates that there is no formation of \[Fe(bipy)~3~\]^2+^ and, consequently, no mobilization of BfrB from the iron core. Thus, Bfd is necessary for the efficient and quantitative mobilization of Fe^2+^ from BfrB.

Similar experiments conducted with the BfrB mutants show that the mutations significantly decrease the efficiency of iron mobilization: Replacement of Leu^68^, Glu^81^, or Glu^85^ for Ala causes significant decrease in the rate of iron release from BfrB, as shown by the cyan, green, and orange traces in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A. It is noteworthy that iron release from the Leu^68^Ala/Glu^81^Ala double mutant is nearly completely abolished, as shown by the blue trace. To facilitate a more quantitative comparison of the effect of the mutations on the rates of iron mobilization, the initial rates of iron mobilization were obtained from fitting the initial, linear part of the curves (0 to ∼4 min) to a linear function ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

###### Dissociation Constants for the BfrB:Bfd Interaction Involving Mutant BfrB and Bfd Molecules and Corresponding Initial Rates of Iron Release from the Core of BfrB

  protein          *K*~d~ (μM) (pH 7.4)   initial rate (min^--1^)
  ---------------- ---------------------- -------------------------
  wild type        3.3 ± 0.5              0.099 ± 0.007
  BfrB E81A        258.5 ± 21.5           0.031 ± 0.0003
  BfrB L68A        298.5 ± 20.5           0.019 ± 0.0003
  BfrB E85A        590 ± 2                0.018 ± 0.0006
  BfrB L68A/E81A   not measurable         not measurable
  Bfd Y2F          10.7 ± 0.2             0.097 ± 0.004
  Bfd K40A         7.7 ± 0.5              0.090 ± 0.002
  Bfd L5A          82 ± 2.5               0.044 ± 0.0005

The accompanying plots in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B track the time-dependent shift of the Soret band from 418 nm (oxidized heme) to 425 nm (reduced heme). In the case of wt BfrB, as the iron mobilization process progresses and the Fe^3+^ mineral core has been ≈80% mobilized, the heme is completely reduced, indicating that when the iron core is significantly diminished the flux of electron transfer from Bfd to heme in BfrB is faster than the flux of electron transfer from the heme to the Fe^3+^ core. When L^68^A, E^81^A, or E^85^A are utilized, reduced heme accumulates more gradually, and the corresponding ferric cores are mobilized more slowly than that in wt BfrB. In the case of the E^81^A/L^68^A BfrB mutant, the Fe^3+^ core is not mobilized ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A), and the heme remains oxidized (Soret band remains at 418 nm). These observations are consistent with the idea that the interaction between L^68^A/E^81^A BfrB and Bfd is blocked, which inhibits electron transfer and Fe^3+^ mobilization. Taken together, the observations summarized in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"} indicate that Bfd and BfrB single mutants undergo interactions conducive to electron transfer less frequently than Bfd and wt BfrB and that interactions between L^68^A/E^81^A BfrB and Bfd, if they occur at all, are not conducive to electron transfer.

![Mobilization of Fe^3+^ stored in mutant BfrBs designed to block the BfrB:Bfd interaction is impaired. (A) Time-dependent increase in the normalized Δ*A*~523~ upon addition of excess NADPH (final concentration, 1.0 mM) to 20 mM phosphate buffer (pH 7.6) containing 0.9 μM wt Bfd, 7.2 μM Fpr, and 0.18 μM of wt (black), E^81^A (green), L^68^A (cyan), E^85^A (orange), L^68^A/E^81^A BfrB (blue) or no BfrB (red). (B) Time-dependent changes in the position of the heme Soret band in BfrB on addition of NADPH to the solutions in panel A; 418 and 425 nm correspond to fully oxidized and fully reduced heme, respectively.](bi-2015-00937b_0007){#fig6}

The BfrB Mutants Have Significantly Reduced Affinity for Bfd {#sec3.6}
------------------------------------------------------------

The findings described in the section above suggest that, relative to wt BfrB, the BfrB mutants form less stable complexes with Bfd. Experimental support for this idea was obtained by measuring the *K*~d~ for the associations between Bfd and each of the BfrB mutants using SPR, in a manner similar to that described above for the association between wt BfrB and Bfd. [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A--D illustrates the reference- and baseline-subtracted responses obtained from flowing Bfd over immobilized L^68^A, E^81^A, E^85^A, and L^68^A/E^81^A BfrB, respectively. For each of the mutants, the corresponding response reaches a plateau at each of the Bfd concentrations, indicating steady-state equilibrium. Plotting each response at steady state as a function of Bfd concentration produces the binding plots defined by the black (E^81^A), red (L^68^A), and green (E^85^A) circles in [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}E. Fitting the data to [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"} produced the corresponding *K*~d~ values, which are listed in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The data shows that the association between Bfd and L^68^A or E^81^A BfrB is ≈100 times weaker than the corresponding association with wt BfrB and that the E^85^A mutation results in the lowest affinity for Bfd, which is ≈170 times lower than that measured for wt BfrB. Note that the reference- and baseline-subtracted responses obtained from flowing Bfd over immobilized L^68^A/E^81^A BfrB ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}D) indicate that the association between these two proteins is undetectable by SPR. The affinity of Bfd for BfrB decreases in the order wt ≫ E^81^A ≈ L^68^A \> E^85^A ≫ L^68^A/E^81^A ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), which suggests that the efficiency of core iron mobilization might follow a similar order. The pseudo rate constants of iron mobilization, however, follow the order wt ≫ E^81^A \> L^68^A ≈ E^85^A ≫ L^68^A/E^81^A. The explanation for these seeming discrepancies probably resides in the fact that binding affinity is not the only determinant for electron transfer between the two proteins. Rather, interactions conducive to electron transfer must place the \[2Fe--2S\] cluster of Bfd in relative close (optimum) proximity to the heme in BfrB so that electron transfer is facilitated. Consequently, although the binding affinity of L^68^A \> E^85^A, it is possible that E^85^A interacts with Bfd in a manner conducive to electron transfer more frequently than does the L^68^A mutant.

![Binding affinity of Bfd for mutant BfrBs is diminished. Overlay of reference- and baseline-subtracted sensograms resulting from flowing wt Bfd at the indicated concentrations over immobilized (A) L^68^A, (B) E^81^A, (C) E^85^A, and (D) L^68^A/E^81^A BfrB. (E) Responses at steady state were plotted as a function of Bfd concentration and fitted to the model described by [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"}.](bi-2015-00937b_0008){#fig7}

Structural Characterization of BfrB Mutants {#sec3.7}
-------------------------------------------

The X-ray crystal structure of wt BfrB is nearly identical to the previously reported structure of M^0^ BfrB (PDB 3IS7); superposition^[@ref43]^ of subunit A of wt BfrB with subunit A of M^0^ BfrB resulted in 0.20 Å RMSD between C~α~ atoms for the 153 residues aligned using secondary structure matching.^[@ref44]^ Superposition of the wt BfrB structure with the structures of each of the BfrB mutants in this study shows that the overall organization of the mutants is nearly identical to that of the wt protein. The RMSD values (C~α~ atoms) obtained from superposing subunit A of wt BfrB with subunit A of L^68^A, E^81^A, E^85^A, and L^68^A/E^81^A BfrB are 0.19, 0.25, 0.22, and 0.15 Å, respectively, for 156 residues aligned. Our previous work showed that in all structures of as-isolated M^0^ BfrB the ferroxidase centers are devoid of iron. Soaking crystals of as-isolated protein in crystallization solution containing FeCl~2~, however, invariably resulted in iron binding at the ferroxidase centers. We also noted that iron binding is always accompanied by a conformation change of the ferroxidase center ligand H^130^ side chain from a gate-open to gate-closed state.^[@ref9],[@ref27]^ Hence, it is not surprising that in this study soaking crystals of wt and mutant BfrBs in FeCl~2~ solution resulted in iron binding to the ferroxidase centers and in conformation change of the H^130^ side chain from gate open to gate closed ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)). Interestingly, the ferroxidase iron ions in wt and L^68^A/E^81^A BfrB are also bridged by an acetate ion obtained from the crystallization buffer. These observations, which indicate that the ferroxidase centers in the mutant BfrB molecules are functional *in crystallo*, are in good agreement with ferroxidase center competency in solution, as demonstrated in the above-described Fe^2+^ oxidation and Fe^3+^ uptake efficiency in solution ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)). Consequently, it is clear that the mutations do not affect the iron oxidation function or the global structure of BfrB. As will be shown below, small structural changes observed in each of the BfrB mutants near the mutated residue are consistent with their lower binding affinity for Bfd.

The structure of the BfrB:Bfd complex showed that Bfd binding to BfrB is accompanied by relatively small rearrangements on the BfrB surface.^[@ref12]^ The most significant rearrangements are the reorientation of the L^68^A, E^81^A, and E^85^A side chains on BfrB, which enable hydrophobic and hydrophilic interactions with Bfd: rearrangement of the L^68^ and E^81^ side chains narrows the cleft formed by the two side chains, which serves as a pocket to receive the Y^2^ side chain from Bfd ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}A). The new conformation of the L^68^ side chain also contributes to the narrowing of the pocket where the L^5^ side chain from Bfd anchors on the BfrB surface. The side chain reorientations of E^81^ and E^85^ enable H-bonding interactions between the backbone carbonyl oxygen of Y^2^ in Bfd and the carboxylic group of E^81^, as well as the backbone N--H of M^1^ in Bfd and the carboxylic group in E^81^ and E^85^. These interactions, in turn, allow the side chain of M^1^ in Bfd to pack hydrophobically against the BfrB surface. Close inspection of the Bfd-binding site in L^68^A BfrB ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}B) shows that the conformation of the E^81^ side chain remains as in the wt protein but that the shorter side chain of A^68^ makes the cleft shallower on one side. This is expected to affect the extent to which the Bfd Y^2^ side chain can bind and also affect the pocket where Bfd L^5^ anchors on the BfrB surface. The structure of the E^81^A mutant ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}C) suggests that, in addition to a shallower more open cleft where the anchoring of Y^2^ from Bfd is likely to be less efficient, a hydrogen bond between the NH of M^1^ in Bfd and a carboxyl O in BfrB E^81^ is lost. The shorter A^85^ side chain in the E^85^A mutant ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}D) allows the E^81^ side chain to move away from the cleft and therefore create a wider gap, which is probably unfavorable for efficient anchoring of the Bfd Y^2^ side chain. In addition, the hydrogen bonds between NH of M^1^ in Bfd and the carboxyl oxygens in BfrB E^85^ are no longer possible, which, in turn, may have an unfavorable effect on how the side chain of M^1^ in Bfd packs against the BfrB surface. In aggregate, the E^85^A mutation eliminates more interactions than the L^68^A or E^81^A mutation, which is in agreement with the observation that the *K*~d~ measured for the interaction between Bfd and E^85^A BfrB is approximately 2-fold larger than the *K*~d~ values measured for the complexes formed between Bfd and L^68^A BfrB or E^81^A BfrB ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Finally, the structure of the L^68^A/E^81^A mutant ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}E) shows a very wide cleft, where the Y^2^ side chain in Bfd is unlikely to undergo any meaningful interactions. This is probably the reason that the association between Bfd and the BfrB double mutant is blocked and mobilization of core iron stored in L^68^A/E^81^A BfrB is inhibited.

![Structural changes in the Bfd-binding sites of BfrB mutants. (A) View of the wt BfrB:Bfd interface, showing Bfd residues in cyan sticks and BfrB in surface representation, with subunit A in green and subunit B in gray. (B--E) Identical views of the Bfd-binding sites in the BfrB mutants, illustrating the structural changes in each of the BfrB mutants. O and N atoms are in red, and S and Fe atoms in the \[2Fe--2S\] cluster of Bfd are in yellow and orange, respectively.](bi-2015-00937b_0009){#fig8}

Mutations in Bfd {#sec3.8}
----------------

The X-ray crystal structure of the BfrB:Bfd complex revealed, for the first time, the Bfd fold, which consists of a helix-turn-helix motif, where the four Cys ligands to iron in the \[2Fe--2S\] cluster are located in two hairpin loops ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). Note that iron ligands C^4^ and C^6^ are located in the same hairpin loop (cyan) that contains M^1^, Y^2^, and L^5^, whose side chains anchor Bfd at the BfrB surface. We prepared the Y^2^A, Y^2^F, L^5^A, and K^40^A Bfd mutants to evaluate the effect of the mutations on the association with BfrB and their effectiveness at promoting the mobilization of core iron from BfrB. The L^5^A and K^40^A mutants can be expressed and purified in yields comparable to those of wt Bfd. The mutants display UV--vis spectra nearly identical to that of the wt protein ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)), indicating that they bind a \[2Fe--2S\] cluster. In contrast, Y^2^A Bfd is expressed in the *E. coli* host cells but does not incorporate a \[2Fe--2S\] cluster. Inspection of the wt Bfd structure shows that the Y^2^ side chain contributes to stabilizing the hairpin loop containing C^4^ and C^6^ via packing interactions with G^8^ and T^10^ ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). It is therefore possible that the inability of the Y^2^A mutant to bind a \[2Fe--2S\] cluster is a consequence of conformational disorder in the loop containing iron ligands C^4^ and C^6^. Given that Y^2^A Bfd cannot bind a \[2Fe--2S\] cluster, we prepared the Y^2^F mutant in an attempt to study the role played by the phenolic OH in BfrB:Bfd association and in promoting the mobilization of core iron from BfrB.

![Structural organization of the hairpin loops harboring the iron ligands in the \[2Fe--2S\] cluster of Bfd (PDB 4E6K). The N′-terminus hairpin loop (cyan) contains residues Y^2^ and L^5^ and iron ligands C^4^ and C^6^; packing interactions involving Y^2^, G^8^, and T^10^ stabilize the hairpin and the \[2Fe--2S\] cluster. The hairpin loop containing iron ligands C^38^ and C^41^ is shown in green; O, N, S, and Fe atoms are shown in red, blue, yellow, and orange, respectively.](bi-2015-00937b_0010){#fig9}

The dissociation constant for the interaction between BfrB and each of the mutant Bfds was measured using SPR. The corresponding reference- and baseline-subtracted sensograms ([Figures [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}A and [S10](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)) show that each of the systems attains steady-state equilibrium, so *K*~d~ values ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) were obtained from fitting the corresponding data to [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"} ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}B). The *K*~d~ obtained with Y^2^F Bfd is approximately 3 times larger than that measured with wt Bfd, which indicates that the phenol OH in Y^2^ contributes only modestly to stabilizing the BfrB:Bfd complex. This observation is consistent with our analysis of the interface, which shows that anchoring of the Y^2^ side chain engages mainly hydrophobic interactions with L^68^ and E^81^ in BfrB ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C). The *K*~d~ measured with L^5^A Bfd, on the other hand, is ≈30-fold higher than that obtained with wt Bfd, a finding that is also consistent with our analysis of the interface, which suggests that packing of the L^5^ side chain on the BfrB surface is important for the stabilization of the BfrB:Bfd complex. The *K*~d~ obtained with K^40^A Bfd is 2 times larger than the *K*~d~ obtained with wt BfrB. Analysis of the interface shows that the hydrophobic portion of the K^40^ side chain interacts with the hydrophobic portion of BfrB K~A~^76^; in addition, K^40^ forms hydrogen bonds with Q~B~^72^ and L~A~^74^ in BfrB. Although it is possible that the A^40^ side chain in K40A Bfd partially substitutes for the hydrophobic stabilization provided by the K^40^ and BfrB K~A~^76^ packing interaction, the modest increase in *K*~d~ observed with the K^40^A mutant suggests that K^40^ is less important to the stabilization of the BfrB:Bfd complex than Y^2^ and L^5^. The relative stability of the complexes formed between BfrB and mutant Bfds (wt ≈ Y^2^F ≈ K^40^A \> L^5^A) is reflected in the ability of each of these mutants to promote the mobilization of core iron from BfrB ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}C and [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). It is interesting to note that under the conditions of our iron mobilization assay an increase in *K*~d~ of approximately 3 times does not significantly affect the efficiency of iron mobilization. This may be due to the presence of a large excess of NADPH in the cuvette.

![Effect of mutations in Bfd on the binding affinity of the BfrB:Bfd complex and on iron mobilization from wt BfrB. (A) Overlay of reference- and baseline-subtracted sensograms resulting from flowing L^5^A Bfd solution of the indicated concentrations over immobilized wt BfrB. (B) Responses at steady state plotted as a function of the concentration of wt (blue), L^5^A (red), Y^2^F (black), and K^40^A Bfd (green). (C) Time-dependent increase in the normalized Δ*A*~523~ upon addition of excess NADPH (final concentration, 1.0 mM) to 20 mM phosphate buffer (pH 7.6) containing 0.18 μM wt BfrB, 7.2 μM Fpr, and 0.9 μM wt (blue), Y^2^F (black), L^5^A (red), or K^40^A Bfd (green).](bi-2015-00937b_0011){#fig10}

Concluding Remarks {#sec3.9}
------------------

In this study, we have dissected the BfrB:Bfd interface to validate the model obtained from the X-ray crystal structure and to gain a greater understanding of the interactions that contribute to the stability of this protein--protein complex. The results, which demonstrate that replacing key residues at the protein--protein interface for alanine lowers the strength of the association and impairs core iron mobilization, are in excellent agreement with the structural model, which places the \[2Fe--2S\] cluster in Bfd immediately above the heme in BfrB to facilitate electron transfer. Our findings also provide significant insight into factors that contribute to the stability of the BfrB:Bfd complex. In this context, it is important to note that although the number of structures of protein--protein complexes is relatively limited, analysis of protein--protein complexes has shown that not all residues participating at protein--protein interfaces contribute equally to the stability of the complex. Rather, there are critical residues that contribute to the majority of the binding energy. Thus, these have been termed hot spot residues. Hot spot residues can be identified by alanine-scanning mutagenesis, if their substitution by alanine leads to a binding energy difference of at least 2 kcal/mol (ΔΔ*G* ≥ 2 kcal/mol).^[@ref45]−[@ref47]^ Hot spot residues tend to occur in clusters, which often form a network of interactions constituting hot regions; importantly, such a hot region includes residues from both proteins.^[@ref48]^ Our results, which show that replacing L~B~^68^, E~A~^81^, and E~A~^85^ in BfrB and L^5^ in Bfd for alanine results in ΔΔ*G* ≥ 2 kcal/mol, clearly identify these as hot spot residues ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}A). A zoomed-in view of the BfrB:Bfd interface ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}B) illustrates how these critical residues form a clustered network of packing interactions that define a hot region. The figure also makes it evident that Y^2^ in Bfd is probably an integral component of the hot region. As pointed out above, the Y^2^A Bfd mutant cannot bind a \[2Fe--2S\] cluster and therefore could not be studied. Nevertheless, the structure suggests that hydrophobic packing of its aromatic side chain with the L~B~^68^ side chain and the hydrophobic portion of the E~A~^81^ side chain in BfrB dominate the contribution of Y^2^ to the stability of the complex. Identification of the hot spot residues in both proteins, as well as visualization of the hot region, makes it apparent that a large portion of the hot spot interactions is eliminated from the hot region by replacing E~A~^81^ and E~A~^85^ in BfrB for alanine, which should significantly decrease the binding affinity, a prediction that is reflected in the observation that Bfd cannot bind to L^68^A/E^81^A BfrB. Finally, it is noteworthy that all of the hot spot residues identified in this investigation are conserved in the Bfr and Bfd sequences ([Figure S11](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)) of a large number of Gram-negative pathogens, where the *bfr* and *bfd* genes are also contiguous in the corresponding chromosomes ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Consequently, conservation in the arrangement of these genes in the chromosomes of many pathogens and conservation of hot spot residues in both proteins indicate that the hot region that stabilizes the BfrB:Bfd association in *P. aeruginosa* is likely to be of widespread significance in bacterial iron metabolism.

![Identification of hot spot residues at the interface of the BfrB:Bfd complex. (A) Change in binding free energy (ΔΔ*G*) brought by mutations in BfrB (green for subunit A; gray for subunit B) or in Bfd (cyan). (B) Zoomed-in view of the BfrB:Bfd interface depicting how hot spot residues network into a hot region; O is in red, and N is in blue.](bi-2015-00937b_0012){#fig11}

###### Pathogens Where Adjacent *bfd* and *bfr* Genes Code Conserved Hot Spot Residues in the Corresponding Bfr and Bfd Sequences

                                        locus ID       
  ------------------------------------- -------------- --------------
  *Pseudomonas aeruginosa* PAO1         PA3530         PA3531
  *Escherichia coli* O157               Z4696          Z4695
  *Escherichia coli* K12                b3337          b3336
  *Salmonella typhimurium*              STM3444        STM3443
  *Salmonella enterica* serovar Typhi   t4061          t4062
  *Salmonella enterica* choleraesuis    SCH_3377       SCH_3378
  *Klebsiella pneumonia*                KPN_03722      KPN_03723
  *Yersinia pestis*                     YPO0205        YPO0206
  *Yersinia pseudotuberculosis*         YPTB3701       YPTB3700
  *Yersinia enterocolitica*             YE3926         YE3925
  *Aeromonas salmonicida*               ASA_0466       ASA_0467
  *Vibrio cholerae* El                  VC_0364        VC_0365
  *Vibrio cholerae*                     VC0395_A2775   VC0395_A2776
  *Vibrio vulnificus*                   VV1_1340       VV1_1341
  *Shigella flexneri* 2a 2457T          S4406          S4407
  *Shigella flexneri* 2a str301         AAN44819.1     AAN44818.1
  *Shigella dysenteriae*                SDY_3499       SDY_3498
  *Erwinia carotovora*                  ECA4033        ECA4034
  *Enterobacter cloacae*                ECL_04701      ECL_04700
  *Serratia sp.*                        SerAS12_4646   SerAS12_4645
  *Citrobacter koseri*                  CKO_04744      CKO_04743
  *Acinetobacter sp.*                   ACIAD3328      ACIAD3330

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.biochem.5b00937](http://pubs.acs.org/doi/abs/10.1021/acs.biochem.5b00937).Arsenic ion bound to the 4-fold pores of L^68^A BfrB (Figure S1); Mg ion in the B-pore of L^68^A BfrB (Figure S2); ITC and SPR analyses of the interaction between Bfd and M^0^ BfrB (Figures S3 and S4); elution volumes of wt and mutant BfrBs from a calibrated size exclusion column (Figure S5); oxidized and reduced spectra of wt and mutant BfrBs (Figure S6); UV--vis spectra obtained from iron uptake of wt and mutant BfrBs (Figure S7); superposition of the ferroxidase centers of native and iron bound wt and L^68^A/E^81^A BfrB (Figure S8); UV--vis spectra of wt and mutant Bfds (Figure S9); overlay of double referenced sensorgrams resulting from injecting Bfd Y^2^F and Bfd K^40^A over immobilized BfrB (Figure S10); sequence alignment of *bfd* and *bfrb* genes from different pathogens (Figure S11); sequence of primer pairs used to introduce the sited-directed mutations; crystallographic data for wt and mutant BfrB structures (Table S1) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf)).
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Coordinates and crystallographic structure factors for the distinct BfrB structures have been deposited in the Protein Data Bank under accession codes listed in Table S1 of the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.5b00937/suppl_file/bi5b00937_si_001.pdf).
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